Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Genzyme Diagnostics Go To Japan’s Sekisui

by Michael McCoy
November 22, 2010 | A version of this story appeared in Volume 88, Issue 47

Genzyme has agreed to sell its diagnostics business to Japan’s Sekisui Chemical for $265 million. With 2009 sales of $167 million, the business provides raw materials, enzymes, chemistry reagents, and rapid tests used to make diagnostics for various diseases. It’s one of three businesses that Genzyme put up for sale in May. Three months later, Genzyme turned down a takeover offer by Sanofi-Aventis. Sekisui has supplied diagnostic raw materials to Genzyme since 1995.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.